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ABSTRACT
The clinical signiﬁcance of coagulase-negative staphylococci isolated from blood culture is typically
assessed on the basis of a combination of clinical and microbiological criteria. However, these criteria are
difﬁcult to apply to haematology patients who are highly immunosuppressed and from whom blood
cultures are obtained most frequently through a central venous catheter. This study analysed 112
episodes of Staphylococcus epidermidis bacteraemia that occurred in 79 bone marrow transplant recipients.
In 73 (65%) episodes, only one blood culture set was positive for S. epidermidis, while 39 (35%) episodes
grew S. epidermidis from multiple blood cultures. Nine patients had two or more episodes of bacteraemia
with the same strain, as determined by pulsed-ﬁeld gel electrophoresis (PFGE). The PFGE method also
showed that 34 (31%) isolates belonged to seven clusters, indicating the persistence of certain clones in
the environment. Of the 109 isolates analysed, 59 (54%) produced bioﬁlm and 91 (83.5%) carried the ica
operon. Isolates that produced bioﬁlm were observed to colonise central venous catheters faster than
non-bioﬁlm-producing isolates (18 vs. 37 days; p 0.03). No clinical features were associated with carriage
of the ica operon, but the ica operon was carried more frequently by the isolates that formed clusters.
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INTRODUCTION
Coagulase-negative staphylococci (CNS) have
emerged as a frequent cause of device-related
infection [1]. Criteria proposed for decisions on
clinical signiﬁcance and treatment remain difﬁcult
to apply in clinical practice, especially in haema-
tology and neonatal intensive care units, where
blood cultures are obtained most frequently
through central venous catheters [2]. A single
blood culture growing CNS is usually considered
to result from contamination, whereas multiple
positive blood cultures are thought to represent
true infection. However, Peacock et al. [3] have
shown that a single positive blood culture bottle
can also reﬂect the presence of a true infection.
An alternative way to differentiate contami-
nants from pathogens would be to investigate the
presence of virulence factors identiﬁed in CNS
strains, such as bioﬁlm production and the inter-
cellular adhesin (ica) ADBC operon [4,5]. It has
been shown that the ica operon, encoding the
production of polysaccharide intercellular adhe-
sin (PIA), is detected signiﬁcantly more fre-
quently in infecting than in contaminating
strains [6–8].
The aims of the present study were to
investigate S. epidermidis bacteraemia in bone
marrow transplant (BMT) recipients, to compare
the clinical features of bacteraemia when one or
several blood cultures were positive, and to
assess whether detection of bioﬁlm production
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and ⁄ or the presence of the ica operon could
help physicians to decide whether to prescribe
glycopeptides.
MATERIALS AND METHODS
BMT recipients
Seventy-nine patients (53 autologous and 26 allogeneic BMT
recipients) were investigated during the 4-year period of the
study. The following data were collected for each patient:
gender, age, disease, allogeneic or autologous graft, and type
of conditioning chemotherapy. For each blood culture set, both
aerobic and anaerobic bottles were inoculated with 10 mL of
blood obtained through the central venous catheter. Usually,
two or three sets of blood cultures were obtained in the case of
fever (temperature of > 38.5C or ‡ 38C for > 12 h). Bacterae-
mia was deﬁned as a positive culture in at least one blood
culture bottle. Positive sequential blood cultures were consid-
ered to belong to the same infectious episode if they occurred
within 72 h of each other. The following data were collected for
each instance of S. epidermidis bacteraemia: date of catheter
insertion; date of onset of bacteraemia; administration of
antimicrobial prophylaxis with co-trimoxazole before the onset
of bacteraemia; date of catheter removal; inﬂammatory or
purulent aspect of the catheter insertion site; presence of fever,
shivers, hypotension, septic shock or localised infection;
increase in serum creatinin level (>110 lmol ⁄L); initiation of
antimicrobial therapy; outcome of therapy; and duration of
hospitalisation.
Bacterial isolates
S. epidermidis isolates (n = 112) from blood cultures obtained
from BMT recipients treated at Nantes hospital between 1993
and 1998 were included in the study. Bacterial isolates were
characterised by standard microbiological procedures. CNS
were identiﬁed to the species level using the coagulase test
and the ID32 STAPH biotyping system (bioMe´rieux, Marcy
l’Etoile, France). Antibiotic susceptibility was tested by the
agar diffusion method according to CA-SFM guidelines
(http://www.sfm.asso.fr). The bioﬁlm-forming and PIA-pro-
ducing strain S. epidermidis RP62A was used as a positive
control [9]. The bioﬁlm-negative strain Staphylococcus hominis
SP2 and the ica-negative strain Staphylococcus schleiferi schleiferi
ATCC 43808 were used as negative controls for bioﬁlm
production [9,10].
Pulsed-ﬁeld gel electrophoresis (PFGE)
DNA isolation and PFGE were performed as described
previously with minor modiﬁcations [11]. S. epidermidis iso-
lates were grown from a single colony overnight at 37C. Next,
0.3 mL of this bacterial suspension was mixed with 2 lL of
lysostaphin Ambicin L and 300 lL of low melting temperature
agarose 2% w ⁄v. The resulting agarose blocks were incubated
for 3 h at 25C in 120 lL of restriction buffer containing 40 U of
SmaI. Electrophoresis was performed in an agarose 1% w ⁄v
gel in a CHEF DR III apparatus (Bio-Rad, Hercules, CA, USA),
with a constant voltage of 200 V and a pulse time increasing
from 5 to 40 s over 20 h. Strain NCTC 8523 was used as a DNA
size marker. Banding patterns were interpreted according to
Tenover et al. [12].
PCR and primers for icaABCD
In total, 109 isolates were available for analysis of ica operon
carriage and bioﬁlm production. DNA was extracted by
boiling ﬁve colonies for 5 min in 300 lL of distilled water.
The resulting suspension was centrifuged at 12 000 g for
5 min and the supernatant was used as a DNA template.
Four primers were chosen to amplify fragments of the icaA,
icaB, icaC and icaD genes of different lengths (Table 1).
Universal primers targeting 16S rRNA were used as an
internal control [13]. Multiplex PCRs were performed in a
ﬁnal volume of 50 lL containing 10 mM Tris-HCl pH 8.3,
50 mM KCl, 1.5 mM MgCl2, 200 lM each nucleotide,
0.25 lM each primer, 1.25 U Taq DNA polymerase (Promega,
Charbonnieres, France) and 10 lL of the bacterial DNA
extract.
After a 5-min initial denaturation at 94C, PCRs comprised
30 cycles of 30 s at 94C, 30 s at 55C and 1 min at 72C,
followed by a ﬁnal extension step of 7 min at 72C, in a Perkin-
Elmer 480 thermal cycler (PE Applied Biosystems, Cergy-
Pontoise, France). Each PCR run included a control reaction
with no added DNA.
Bioﬁlm production
Bioﬁlm production was determined by the method of Chris-
tensen et al. [9] with some modiﬁcations. Isolates were grown
overnight in 10 mL of trypticase soy broth (TSB) containing
glucose 2.5% w ⁄v, then diluted 1:200 in fresh TSB. Portions
(200 lL) of the resulting suspension were used to inoculate
sterile ﬂat-bottomed 96-well polystyrene microtitre plates
(Greiner Labortechnik, Poitiers, France). After incubation for
24 h at 37C, the supernatant was decanted and the wells were
washed gently twice with phosphate-buffered saline. The cells
remaining in the well were ﬁxed for 10 min with ethanol and
stained with safranin for 30 s. Optical densities were read on a
Universal Microplate Reader (Bio-Tek Instruments, Winooski,
VT, USA) at a wavelength of 492 nm [14,15]. Each isolate was
tested in eight wells. The lower cut-off was chosen as
described by Christensen et al. [9], i.e., approximately three
standard deviations above the mean of non-inoculated (blank)
wells.
Table 1. DNA sequences of ampliﬁcation primers
Target
genes Primer DNA sequence (5¢-3¢)
Product
size (bp) Reference
icaA ica A-F ica A-R GAATCCAAAATTAGGCGCAG AGACCCATGTAATCGATGCG 455 This work
icaB ica B-F ica B-R TTAAAGCACACGACGCAAAG TTTCTTCATCGAATCCGTCC 603 This work
icaC ica C-F ica C-R TTATCGCTGTTTCCGGTAGTG CTCTTAACATCATTCCGACGC 300 This work
icaD ica D-F ica D-R ACAGAGGCAATATCCAACGG CGTGTTTTCAACATTTAATGCAA 184 This work
16S rRNA GGAGGAAGGTGGGGATGACG ATGGTGTGACGGGCGGTGTG 241 [13]
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Statistical analysis
Data were analysed using the Epi info computer database (v.6;
CDC, Atlanta, GA, USA). Fisher’s two-tailed exact test and the
chi-square test were used to test the signiﬁcance of association.
For comparison of duration, the F-test of ANOVA was used if the
variance of samples was homogeneous, and the test of
Kruskal–Wallis was used if the variance was heterogeneous.
RESULTS
Characteristics of BMT recipients with
S. epidermidis bacteraemia
In total, 112 S. epidermidis isolates were recovered
from the blood of 79 patients, of whom 26 were
allogeneic BMT recipients and 53 were autolo-
gous BMT recipients. The male:female ratio was
1.8, and the median age was 48 years (range 16–68
years). The characteristics of the patients and the
episodes of bacteraemia are summarised in Tables
2 and 3. Eleven (14%) patients died during
hospitalisation, but no deaths were attributed to
S. epidermidis infection.
Characteristics of S. epidermidis blood cultures
In 73 (65%) episodes of bacteraemia, only one set
of blood cultures was positive for S. epidermidis,
while multiple blood cultures grew S. epidermidis
in 39 (35%) episodes of bacteraemia (median:
three positive blood cultures, range two to six).
Most (80%) isolates were resistant to methicillin.
Another microorganism was isolated concomit-
antly in 14 episodes of bacteraemia involving
single blood cultures, and in six episodes of
bacteraemia involving multiple blood cultures
(Table 4).
When the characteristics of patients with a
single positive blood culture were compared with
those of patients with multiple positive blood
cultures, shivers was the only sign associated
signiﬁcantly with the latter group (18 ⁄ 39 (46%)
vs. 20 ⁄ 73 (27.4%); p 0.04, relative risk (RR) = 1.67,
95% CI 1.02–2.73). Treatment with a glycopeptide
was started for 36 (92.3%) of 39 patients with
multiple positive blood cultures, and for 59
(80.8%) of 73 patients with a single positive blood
culture (p 0.1). Apyrexia following the adminis-
tration of a glycopeptide was observed more often
in patients with multiple positive blood cultures
than in patients with a single positive blood
culture (22 ⁄ 36 (61.1%) vs. 24 ⁄ 59 (40.6%); p 0.05,
Table 2. Characteristics of 26 allogeneic and the 53
autologous bone marrow transplant recipients
Characteristic
Allogeneic
bone marrow
transplantation
patients
Autologous
bone marrow
transplantation
patients
Male gender 14 (54%) 37 (70%)
Age at transplantation, median years
(range)
37 (16–56) 54 (27–68)
Underlying disease
Myeloma 1 (4%) 20 (38%)
Lymphoma 1 (4%) 17 (32%)
Hodgkin’s disease 1 (2%)
Acute leukaemia 17 (65%) 5 (9%)
Chronic leukaemia 5 (19%) 7 (13%)
Other 2 (8%) 3 (6%)
Conditioning regimen
Melphalan, 200 mg ⁄m2 16 (30%)
Cyclophosphamide and TBI 15 (58%) 10 (19%)
VP16, cyclophosphamide and TBI 3 (11.5%)
Melphalan, 140 mg ⁄m2, and TBI 8 (15%)
BEAM 8 (15%)
Melphalan ⁄ busulfan 2 (4%)
CBV and TBI 4 (15%) 2 (4%)
Cyclophosphamide and busulfan 1 (4%) 2 (4%)
Other 3 (11.5%) 5 (9%)
BEAM, carmustine, etoposide, aracytine and melphalan; CBV, cyclophosphamide,
carmustine and etoposide; TBI, total body irradiation.
Table 3. Data collected for 112 episodes of Staphylococcus
epidermidis bacteraemia
Characteristic n %
Prophylaxis 61 54.5
Fever: median (range) 39 C (37–40.5 C)
Shivers 38 34
Hypotension 4 3.5
Septic shock 2 2
Increased serum creatinin level 18 16
Localised infection 36 32
Catheter 11
Lung 11
Skin 8
Other 6
Inﬂammatory aspect of the catheter 40 36
Purulent aspect of the catheter 7 6
Length of hospitalisation: median (range) 21 days (0–98 days)
Duration between catheter insertion and
bacteraemia: median (range)
22 days (1–99 days)
Administration of glycopeptide 94 85
Apyrexia following glycopeptide administration 32a 34
Administration of amphotericin B 59 53
aTotal n = 94.
Table 4. Other microorganisms isolated concomitantly
with Staphylococcus epidermidis
Microorganism
Single positive blood
culture (n = 14)
Multiple positive
blood cultures (n = 6)
Staphylococcus haemolyticus 3 1
Pseudomonas aeruginosa 2
Viridans streptococci 2 3
Enterobacteriaceae 2
Enterococcus faecalis 1
Candida albicans 1
Candida parapsilosis 1
Corynebacterium spp. 1
Corynebacterium spp.
plus S. haemolyticus
1
Viridans streptococci
plus Enterobacteriaceae
1
Viridans streptococci
plus Staphylococcus hominis
1
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RR = 1.67, 95% CI 0.98–2.86). The results obtained
were similar when bacteraemias in which another
microorganism was associated with S. epidermidis
were excluded.
PFGE
In total, 23 (29%) of 79 patients had more than one
episode of S. epidermidis bacteraemia. Of these,
PFGE demonstrated that episodes in 11 patients
were caused by unrelated strains (two episodes in
eight patients; three episodes in three patients),
and in nine patients by related (‘persistent’)
strains (two episodes in six patients; three epi-
sodes in two patients; four episodes in one
patient), and in three patients by both related
and unrelated strains.
Thirty-four (30.3%) isolates belonged to seven
clusters: cluster 1 included 11 related (> 85%
similarity) isolates from 1993 to 1996; cluster 2
included 11 related isolates from 1993 to 1995;
clusters 3 and 4 each included three related
isolates; and clusters 5, 6 and 7 each included
two related isolates.
PCR for ica operon
All 109 isolates analysed were positive for 16S
rRNA, with 91 (83.5%) also carrying the entire ica
operon (icaA, icaB, icaC and icaD genes). Detection
of the ica operon was not associated with any
speciﬁc clinical or biological features, and did not
differ signiﬁcantly (p 0.8) among isolates from
episodes involving single (60 ⁄ 71; 84.5%) or mul-
tiple (31 ⁄ 38; 81.6%) blood cultures. The median
interval between catheter insertion and occur-
rence of bacteraemia was 25 days (range 1–99
days) for the isolates carrying the ica operon and
15 days (range 7–47 days) for the ica-negative
isolates (p 0.07). The results did not differ signi-
ﬁcantly when the analysis was restricted to
patients who had another microorganism isolated
concomitantly from blood.
Bioﬁlm production
In total, 109 isolates were analysed at least three
times. Bioﬁlmwasproducedby 59 (54.1%) isolates,
was not produced by 39 (35.8%) isolates, andmajor
discrepancies were found with 11 (10.1%) isolates
(strongpositive vs. negative),whichwere excluded
subsequently from the study.
With the exception of serum creatinine level,
bioﬁlm production was not associated signiﬁ-
cantly with any of the clinical features analysed or
with the number of positive blood cultures (63%
of isolates from a single positive blood culture
produced bioﬁlm, compared with 54.5% of iso-
lates from multiple positive blood cultures; p 0.4).
The serum creatinine level increased signiﬁcantly
more frequently during bacteraemias caused by
bioﬁlm-producing isolates than during bacterae-
mias caused by non-bioﬁlm-producing isolates
(14 ⁄ 59 vs. 3 ⁄ 39; p 0.03, RR = 1.50, 95% CI 1.11–
2.01). The median interval between catheter inser-
tion and onset of bacteraemia was signiﬁcantly
shorter (p 0.03) for bacteraemias caused by
bioﬁlm-producing isolates (18 days) than for
bacteraemias caused by non-bioﬁlm-producing
isolates (37 days).
Relationship between ica operon carriage and
bioﬁlm production
After excluding the isolates with discrepant
measures of bioﬁlm production, no signiﬁcant
association was observed between ica operon
carriage and production of bioﬁlm: 49 (60.5%) of
the 81 ica-positive isolates produced bioﬁlm and
32 (39.5%) did not, compared with ten (58.8%) of
the 17 ica-negative strains that produced bioﬁlm
and seven (41.2%) that did not (p 0.8). No
difference was found in clinical features, number
of blood cultures or outcome following glycopep-
tide administration between bioﬁlm-producing
ica-positive (n = 49) and non-producing ica-posit-
ive (n = 32) isolates. A signiﬁcant increase in
serum creatinine level was conﬁrmed in associ-
ation with ica-positive bioﬁlm-producing isolates
(13 ⁄ 49 (26.5%) vs. 2 ⁄ 32 (6%); p 0.02, RR = 1.59,
95% CI 1.18–2.14). The median interval between
catheter insertion and onset of bacteraemia was
signiﬁcantly shorter (p 0.02) for bacteraemias
caused by bioﬁlm-producing ica-positive isolates
(22 days) than for bacteraemias caused by
non-producing ica-positive isolates (40 days).
Relationship between PFGE proﬁles, bioﬁlm
production and ica operon carriage
Of the 28 ‘persistent’ isolates from patients pre-
senting with more than one episode of bacterae-
mia, 26 ⁄ 26 carried the ica operon, while the
remaining two isolates were not available for
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analysis. In contrast, of the 83 unrelated isolates,
65 (78.3%) carried the ica operon (p 0.004, RR =
1.28, 95% CI 1.14–1.23). No difference in bioﬁlm
production was observed between these groups
of isolates. The ica operon was found more
frequently in clustered isolates than in unclus-
tered isolates (31 ⁄ 33 (93.9%) vs. 60 ⁄ 76 (78.9%); p
0.05, RR = 1.28, 95% CI 1.14–1.43). Again, no
difference in bioﬁlm production was observed
between these groups of isolates.
DISCUSSION
Despite their supposed low virulence, CNS, and
especially S. epidermidis, are now the most com-
mon organisms isolated from infections of
implanted medical devices [1,16]. The immune
status of the patients and the capacity of the
bacteria to adhere to foreign bodies are the main
factors involved in the pathogenesis of S. epider-
midis. Despite attempts to determine a reference
standard for assessing the pathogenicity of these
strains by a combination of clinical and microbio-
logical ﬁndings, these criteria remain difﬁcult to
apply in clinical practice, especially in haemato-
logical and neonatal intensive care units [2].
Therefore, the present study aimed to determine
whether bioﬁlm production and ⁄ or detection of
the ica operon could be used to assess the
virulence of S. epidermidis strains isolated from
blood cultures in BMT recipients, and thus help
physicians in deciding whether to prescribe
glycopeptides. Unfortunately, the present results
suggest that these indicators cannot be used for
that purpose. Nevertheless, there are some inter-
esting ﬁndings.
First, there were some clinical differences
between patients presenting with single or mul-
tiple positive blood cultures. In the present study,
a number of S. epidermidis bacteraemias were
associated with only one positive blood culture,
and > 80% of these were treated with glycopep-
tides. Only one clinical sign, the presence of
shivers, was signiﬁcantly more common in
patients with multiple positive blood cultures.
Second, although bioﬁlm production per se
cannot be used to decide on the need to treat S.
epidermidis bacteraemias, differences were found
between patients infected by isolates either
producing or failing to produce bioﬁlm. Several
studies have attempted to evaluate the role of
bioﬁlm production in virulence, but the results
have been somewhat contradictory [17–20]. How-
ever, recent clinical studies have suggested that
PIA is important for bioﬁlmaccumulation, and that
the presence of the icaADBC operon coding for PIA
is related to the clinical signiﬁcance of S. epidermidis
isolates [4–8,21–23]. In the present study, bioﬁlm
production was associated with a shorter interval
between catheter insertion and the onset of bacter-
aemia, suggesting that bioﬁlm-producing strains
colonise catheters more rapidly than non-produc-
ers. Bioﬁlm productionwas also associatedwith an
increase in creatinine serum level.
Third, although detection of the ica operon
cannot be used to assess the virulence of S.
epidermidis isolates, the presence of this operon
is associated with important epidemiological
characteristics. As the present study involved
patients with central venous catheters, the pres-
ence of the ica operon in 83% of the isolates
analysed was consistent with published data
showing that the ica operon is found more
frequently in catheter-colonising isolates [22–24].
These data indicate that strains carrying the ica
operon have a competitive advantage for colo-
nising indwelling medical devices, especially
when the duration of catheterisation is long. In
the present study, the mean interval between
catheter insertion and the onset of bacteraemia
was 22 days, and the duration of catheterisation
was longer in patients with bacteraemias invol-
ving ica-positive isolates (25 days) than in those
with isolates without the ica operon (15 days).
This long duration of catheterisation could have
favoured the selection of ica-positive strains
from among ica-negative strains present on the
skin.
The present study found that 32 of 91 isolates
carrying the ica operon did not produce bioﬁlm.
Regulation of the ica operon appears to be very
complex. Production of PIA is certainly subjected
to on-off switching, and may be involved in S.
epidermidis phase-variation that might improve
bacterial survival and growth under changing
environmental conditions in vivo [25]. Environ-
mental regulation may play an important role in
biomaterial-related disease [8,22,23,26–31].
The present study also showed that, despite
wide dispersion of the S. epidermidis isolates, some
strains could persist in the BMT unit. Persistence
of S. epidermidis clones for a long period has been
demonstrated previously in neonatal, haemato-
logical and cardiac surgery units [32–35].
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However, the pathogenic potential of clonal S.
epidermidis strains remains unclear. In the present
study, clustered isolates were neither related to
the severity of the clinical features nor associated
with catheter-related infection, but carried the ica
operon more frequently than sporadic isolates.
The presence of the ica operonmay be evidence for
the persistence of a particular S. epidermidis strain
in a unit [22,27]. This hypothesis was reinforced by
the fact that the time between insertion of a
catheter and the onset of bacteraemia was longer
in bacteraemia occurring with clustered isolates
and with ica-positive isolates, and by the frequent
presence of the ica operon in persistent strains
isolated from the blood of patients presenting
multiple episodes of bacteraemia.
Despite the limitations associated with retro-
spective studies, S. epidermidis bacteraemia asso-
ciated with a single positive blood culture was
shown to be a very common event in BMT
recipients. The presence of the ica operon was
very common among S. epidermidis isolates from
patients with multiple or single positive blood
cultures. The presence of the ica operon does not
seem to be associated with speciﬁc clinical or
biological features in BMT recipients, but could be
an indicator of strain persistence.
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